OpenVSafe by OpenVAERS
Search V-safe

FTW-45086-76679

3 vaccinations 1 coded response 29 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
748 / OK
Registered
2022-02-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-31
    Dose 1 — Pfizer-BioNTech
  2. 2022-02-01
    Registered in v-safe
  3. 2022-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2022-02-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2022-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2022-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2022-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2022-02-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2022-02-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2022-02-21
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2022-02-22
    Dose 2 — Pfizer-BioNTech
  12. 2022-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2022-03-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2022-03-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-03-15
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-03-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-03-29
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-04-05
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-05-24
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-07-26
    Dose 3 — Pfizer-BioNTech
  21. 2022-07-26
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2022-07-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2022-07-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2022-07-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2022-07-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2022-07-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2022-08-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2022-08-02
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2022-08-09
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-08-23
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-09-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-10-25
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2023-01-24
    Survey response — 6 months, dose 3
    MedDRA: Nasal congestion, Nausea, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    MedDRA releases: 2024-11
  34. 2023-01-24
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  35. 2023-01-25
  36. 2023-01-25
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12022-01-31Pfizer-BioNTech No
22022-02-22Pfizer-BioNTech No
32022-07-26Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasal congestion · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…